Systemic Therapy for Metastatic Non―Clear-Cell Renal Cell Carcinoma: Recent Progress and Future DirectionsCHOWDHURY, Simon; MATRANA, Marc R; TSANG, Christopher et al.Hematology/oncology clinics of North America. 2011, Vol 25, Num 4, issn 0889-8588, ix-x, 853-869 [19 p.]Article

Metastatic Non-Clear Cell Renal Cell Carcinoma Treated With Targeted Therapy Agents: Characterization of Survival Outcome and Application of the International mRCC Database Consortium CriteriaKROEGER, Nils; WANLING XIE; PAL, Sumanta K et al.Cancer. 2013, Vol 119, Num 16, pp 2999-3006, issn 0008-543X, 8 p.Article

Neoadjuvant Temsirolimus Effectiveness in Downstaging Advanced Non―Clear Cell Renal Cell CarcinomaRODRIGUEZ FABA, Oscar; BREDA, Alberto; ROSALES, Antonio et al.European urology. 2010, Vol 58, Num 2, pp 307-310, issn 0302-2838, 4 p.Article

Targeted therapies and the treatment of non-clear cell renal cell carcinomaBELLMUNT, J; DUTCHER, J.Annals of oncology. 2013, Vol 24, Num 7, pp 1730-1740, issn 0923-7534, 11 p.Article

Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinomaLEE, J.-L; AHN, J.-H; KIM, C.-S et al.Annals of oncology. 2012, Vol 23, Num 8, pp 2108-2114, issn 0923-7534, 7 p.Article

A Phase 2 Trial of Sunitinib in Patients with Advanced Non―clear Cell Renal Cell CarcinomaTANNIR, Nizar M; PLIMACK, Elizabeth; APARICIO, Ana et al.European urology. 2012, Vol 62, Num 6, pp 1013-1019, issn 0302-2838, 7 p.Article

The von Hippel-Lindau Gene : Turning Discovery Into TherapyCLARK, Peter E; COOKSON, Michael S.Cancer. 2008, Vol 113, Num 7, pp 1768-1778, issn 0008-543X, 11 p., 1Article

Pathologic T1 clear cell renal cell carcinoma: Insulin-like growth Factor-I receptor expression and disease-specific survivalPARKER, Alexander S; CHEVILLE, John C; BLUTE, Michael L et al.Cancer. 2004, Vol 100, Num 12, pp 2577-2582, issn 0008-543X, 6 p.Article

CD151 expression can predict cancer progression in clear cell renal cell carcinomaYOO, Seong H; LEE, Kyoungbun; CHAE, Ji Y et al.Histopathology. 2011, Vol 58, Num 2, pp 191-197, issn 0309-0167, 7 p.Article

PPARγ is functionally expressed in clear cell renal cell carcinomaCOLLET, Nicolas; THEOLEYRE, Sandrine; RAGEUL, Julie et al.International journal of oncology. 2011, Vol 38, Num 3, pp 851-857, issn 1019-6439, 7 p.Article

Levels of angiogenesis and expression of angiogenesis-related genes are prognostic for organ-specific metastasis of renal cell carcinomaFUKATA, Satoshi; INOUE, Keiji; KAMADA, Masayuki et al.Cancer. 2005, Vol 103, Num 5, pp 931-942, issn 0008-543X, 12 p.Article

Clear cell renal cell carcinoma associated with bilateral atypical acute posterior multifocal placoid pigment epitheliopathyPARMEGGIANI, Francesco; COSTAGLIOLA, Ciro; D'ANGELO, Sergio et al.Oncology. 2004, Vol 66, Num 6, pp 502-509, issn 0030-2414, 8 p.Article

Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinomaHOANG, Mai P; AMIRKHAN, Robin H.The American journal of surgical pathology. 2003, Vol 27, Num 8, pp 1152-1156, issn 0147-5185, 5 p.Article

The evolution of collagen expression in sarcomatoid renal cell carcinomaDELAHUNT, Brett; BETHWAITE, Peter B; MCCREDIE, Margaret R. E et al.Human pathology. 2007, Vol 38, Num 9, pp 1372-1377, issn 0046-8177, 6 p.Article

Clear cell renal cell carcinoma: Contrast-enhanced ultrasound features relation to tumor sizeJUN JIANG; YAQING CHEN; YONGCHANG ZHOU et al.European journal of radiology. 2010, Vol 73, Num 1, pp 162-167, issn 0720-048X, 6 p.Article

Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transitionBOSTRÖM, Anna-Karin; MÖLLER, Christina; NILSSON, Elise et al.Human pathology. 2012, Vol 43, Num 5, pp 708-719, issn 0046-8177, 12 p.Article

Loss of expression of TIMP3 in clear cell renal cell carcinomaMASSON, Damien; RIOUX-LECLERCQ, Nathalie; FERGELOT, Patricia et al.European journal of cancer (1990). 2010, Vol 46, Num 8, pp 1430-1437, issn 0959-8049, 8 p.Article

Multilocular cystic renal cell carcinoma : A report of 45 cases of a kidney tumor of low malignant potentialSUZIGAN, Sueli; LOPEZ-BELTRAN, Antonio; JAPP, Lucia C et al.American journal of clinical pathology. 2006, Vol 125, Num 2, pp 217-222, issn 0002-9173, 6 p.Article

The Distinction of Clear Cell Carcinoma of the Female Genital Tract, Clear Cell Renal Cell Carcinoma, and Translocation-Associated Renal Cell Carcinoma: An Immunohistochemical Study Using Tissue MicroarrayHUIYING HE; ZHOU, Grace X; MING ZHOU et al.International journal of gynecological pathology. 2011, Vol 30, Num 5, pp 425-430, issn 0277-1691, 6 p.Article

Overexpression of the polarity protein PAR-3 in clear cell renal cell carcinoma is associated with poor prognosisDUGAY, F; LE GOFF, X; BELAUD-ROTUREAU, M. A et al.International journal of cancer (Print). 2014, Vol 134, Num 9, pp 2051-2060, issn 0020-7136, 10 p.Article

The allelic loss of chromosome 3p25 with c-myc gain is related to the development of clear-cell renal cell carcinomaYAMAGUCHI, S; YOSHIHIRO, S; MATSUYAMA, H et al.Clinical genetics. 2003, Vol 63, Num 3, pp 184-191, issn 0009-9163, 8 p.Article

Multilayer-omics analysis of renal cell carcinoma, including the whole exome, methylome and transcriptomeARAI, Eri; SAKAMOTO, Hiromi; FUJIMOTO, Hiroyuki et al.International journal of cancer (Print). 2014, Vol 135, Num 6, pp 1330-1342, issn 0020-7136, 13 p.Article

Matrix metalloproteinase-2 and -9 in the sera and in the urine of human oncocytoma and renal cell carcinomaDI CARLO, Angelina.Oncology reports. 2012, Vol 28, Num 3, pp 1051-1056, issn 1021-335X, 6 p.Article

miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215WHITE, Nma; KHELLA, Hwz; EVANS, A. J et al.British journal of cancer. 2011, Vol 105, Num 11, pp 1741-1749, issn 0007-0920, 9 p.Article

Loss of type III transforming growth factor-β receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinomaCOOPER, S. J; ZOU, H; BLOBE, G. C et al.Oncogene (Basingstoke). 2010, Vol 29, Num 20, pp 2905-2915, issn 0950-9232, 11 p.Article